Evidence map›Paper›PMID 36827159›Full record

ArticleMarine drugs2023

Unifying the Synthesis of a Whole Family of Marine Meroterpenoids through a Biosynthetically Inspired Sequence of 1,2-Hydride and Methyl Shifts as Key Step.

Antonio Rosales Martínez, Román Nicolay Rodríguez-Maecker, Ignacio Rodríguez-García

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Antonio Rosales MartínezDepartment of Chemical Engineering, Escuela Politécnica Superior, University of Sevilla, 41011 Sevilla, Spain.ORCID 0000-0003-0182-0548
Román Nicolay Rodríguez-MaeckerDepartment of Energy and Mechanics, Carrera de Ingeniería Petroquímica, Universidad de las Fuerzas Armadas-ESPE, Latacunga 050150, Ecuador.ORCID 0000-0003-1773-402X
Ignacio Rodríguez-GarcíaOrganic Chemistry, ceiA3, CIAIMBITAL, University of Almería, 04120 Almería, Spain.ORCID 0000-0002-2985-8567
Universidad de las Fuerzas Armadas ESPE · ECUniversidad de Sevilla · ESUniversity of Almería · ES

Funding

European Union project 101022507 LAURELINRegional Government of Andalusia project PY20_01027University of Almería Projects UALFEDER 2020-FQM-B1989University of Seville Projects 2020/00001014, 2021/00000422.
6 · The paper itself

Abstract

Marine meroterpenoids have attracted a great deal of attention from synthetic research groups due to their attractive and varied biological activities and their unique and diverse structures. In most cases, however, further biological studies have been severely limited mainly to the scarcity of natural supply and because almost none of the reported syntheses methods has enabled unified access for a large number of marine meroterpenoids with aureane and avarane skeletons. Based on our previous publications and the study of recent manuscripts on marine meroterpenoids, we have conceived a unified strategy for these fascinating marine compounds with aureane or avarane skeletons using available drimane compounds as starting materials. The key step is a biosynthetic sequence of 1,2-hydride and methyl shifts. This strategy is of great synthetic value to access marine meroterpenoids through easy chemical synthetic procedures. Finally, several retrosynthetic proposals are made for the future synthesis of several members of this class of meroterpenoids, focused on consolidating these 1,2-rearrangements as a versatile and unified strategy that could be widely used in the preparation of these marine meroterpenoids.

Indexed as

marine natural productsmeroterpenoidsrearrangementssynthetic strategies

Identifiers

PMID36827159
PMCPMC9962294
OpenAlexW4320494801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.